By considering the five-year survival rates and using both Kaplan-Meier curve and multivariable Cox analysis, we realized that PTCSC3 downregulation is linked to poorer long-term survival and prognosis for prostate cancer patients. Here, PTCSC3 is linked to prostate carcinoma.